Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine prophylaxis for delirium after cerebrovascular intervention
ChiCTR2000039854Phase 4Recruiting
- Sponsor
- Department of Anesthesiology, Shandong Provincial Qianfoshan Hospital
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in delirium comparing Dexmedetomidine treatment group with Placebo control group (2 arms). Primary endpoint: Incidence of delirium within 7 days after study medication. Started Nov 2020; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on ChiCTR2000039854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039854.